CARY, N.C., March 11, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by AVEO Oncology as a specialty pharmacy provider for FOTIVDA® (tivozanib) for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) who have received two or more prior systemic therapies.
FOTIVDA, approved by the U.S. Food and Drug Administration (FDA) on March 10, 2021, is an oral, once-daily vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI). This drug blocks all three VEGF receptors and is designed to optimize VEGF blockade while minimizing side effects.
“FOTIVDA addresses an unmet need in patients with advanced RCC who otherwise lack a vital treatment option that targets their disease while improving quality of life,” said Ela Lourido, vice president of Biopharma Services at Biologics. “Renal cell carcinoma is a complex disease. We are so pleased to distribute this meaningful therapy to patients whose disease has relapsed or become refractory to multiple lines of therapy.”
Biologics specialty pharmacy is committed to and recognized for its level of customer service as well as its innovative, high-touch and multidisciplinary patient-centric approach. Each team includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients. This deeply skilled care team works together to develop individualized care plans that address each patient’s unique clinical, financial and emotional needs and streamlines communication back to the treating provider, enabling high-quality care and differentiated outcomes. In addition, the Biologics team works closely with payers to ensure patients can access the specialty medications they need.
Physicians may submit prescriptions to Biologics via phone (800.850.4306), fax (800.823.4506) or eScribe. For electronic prescribing systems, physicians may search for Biologics within their EMR system.
About Biologics by McKesson
Biologics by McKesson is an independent specialty pharmacy with more than 25 years of experience connecting patients to life-changing medications in oncology and other rare and complex therapeutic areas. Built on the foundation of deep clinical expertise and a high-touch approach to patient care, Biologics delivers seamless access and personalized engagement, so patients get the most out of the care they receive. As a business within McKesson Corporation, Biologics harnesses unparalleled reach and connectivity across the healthcare system to connect the dots between payers, providers and biopharma, so together, they can deliver better care and outcomes for every patient.
Claire Crye, Public Relations